Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News - Page: 2 from PR Newswire

18:11 EST 15th December 2018 | BioPortfolio

Here are the most relevant search results for "PR Newswire" found in our extensive news archives from over 250 global news sources.

More Information about PR Newswire on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about PR Newswire for you to read. Along with our medical data and news we also list PR Newswire Clinical Trials, which are updated daily. BioPortfolio also has a large database of PR Newswire Companies for you to search.

Showing News Articles 26–50 of 353 from PR Newswire

Friday 7th December 2018

China's Shandong province holds Hong Kong-Shandong Week 2018

The event is focused on promoting development of the province's top 10 industries HONG KONG, Dec. 7, 2018 /PRNewswire/ -- Between December 4 and 7, the People's Government of Shandong Province held "Hong Kong-Shandong Week 2018". The event, themed "Select Shandong, Share Opportunities", took place in Hong Kong. On December 5, at the market...

Thursday 6th December 2018

Genkicell Chain Invited to China to Communicate about Project Landing

TOKYO, Dec. 6, 2018 /PRNewswire/ -- Genkicell Chain, Japan's well-known One Health Blockchain project, accompanied by a Japanese delegation on high-tech innovation, recently had a one-week investigation, exchange and visit to three Chinese cities, Nanjing, Hangzhou and Jinhua, to ascertain the potential in the Chinese market and seek opportunities of cooperation in the fields of blockchain, a...

Global Cord Blood Corporation Announces Results of 2018 Annual General Meeting

HONG KONG, Dec. 6, 2018 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2018 Annual General Meeting, which was held on December 5, 2018, in Hong Kong S.A.R., China. ...

WuXi Biologics Wins SCRIP Award for "Best Company in an Emerging Market"

SHANGHAI and LONDON, Dec. 6, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company that offers end-to-end solutions for biologics discovery, development and manufacturing, today announced that it has won the SCRIP Award in the category of "Best Company in an Emerging Market". This award recognizes the rapid growth, significant a...

Tychan Begins Phase I Trials for First Ever Yellow Fever Drug

- Monoclonal antibody TY014 advanced from initiation to clinical development in seven months - Proprietary platform demonstrates potential for rapid intervention against future infectious disease outbreaks SINGAPORE, Dec. 6, 2018 /PRNewswire/ -- Tychan, a clinical-stage biotechnology company based in Singapore, announced today that its first-in-class candidate drug for the treatme...

Gencurix announces further evidences for GenesWell(TM) BCT

SEOUL, South Korea, Dec. 3, 2018 /PRNewswire/ -- Gencurix, the developer of a molecular diagnostic test, GenesWell™ BCT, reported another evidence for the efficacy of the product. GenesWell(TM) BCT full set GenesWell™ BCT is a gene expression profiling test that predicts probability of distant metastasis and recurrence rate within 10 years in patients with

Wednesday 5th December 2018

World Institute of Kimchi: Seven Health Benefits of Korea's Signature Dish, Kimchi

- Analysis on the 590 kimchi-related studies published around the world - Kimchi, a superfood that helps prevent allergies and cancers SEOUL, South Korea, Dec. 5, 2018 /PRNewswire/ -- World Institute of Kimchi, which discovers and promotes kimchi's scientific excellence announces seven health benefits of Korea's signature dish, Kimchi....

Ping An Good Doctor's CPO Wu Zongxun: Joining Hands with Pharmaceutical Enterprises to Build New Pharmaceutical Retail Model

GUANGZHOU, China, Dec. 5, 2018 /PRNewswire/ -- On 4 December 2018, the 80th Session of the National Pharmaceuticals Trade Fair ("Pharm China") debuted in Guangzhou. Mr. Wu Zongxun, the Chief Product Officer of Ping An Health Medical Technology Company Limited ("Ping An Good Doctor", stock code: 01833.HK) was invited to attend the event and delivered a keynote speech titled...

TUV Rheinland: a critical step forward for MicroP medical certifications for dental handpiece

TAIPEI, Dec. 5, 2018 /PRNewswire/ -- The continued growth of the global medical device industry means requisite safety testing and certification for medical devices that can be quite challenging before they are released to market. On November 30, MicroP, a dental handpiece maker in Taiwan, announced that it has successfully obtained ISO 13485:2016 certification, as well as CE Marking and FDA 510(k...

Chinese drugmaker Changzhou Qianhong Bio-pharma starts construction of RMB 1 billion facility to expand production of polysaccharides and enzymes drugs

CHANGZHOU, China, Dec. 5, 2018 /PRNewswire/ -- Changzhou Qianhong Bio-pharma Co., Ltd. started construction of the phase two of pharmaceuticals production facility at Changzhou National Hi-Tech District on November 28. With an investment of 1 billion yuan, phase two adds 200 million tablets and 60 million injections to production as well as making molecular diagnosis reagents available for us...

Cedrus' Head of Life Sciences Ms. Kimberly Nearing invited to speak at the BioCentury and Bayhelix's China Healthcare Summit 2018 in Shanghai

HONG KONG, Dec. 5, 2018 /PRNewswire/ -- Ms. Kimberly Nearing, the Managing Director - Life Sciences at Cedrus Investments ("Cedrus"), was invited to speak on a panel at the 5th Annual China Healthcare Summit in 2018 in Shanghai hosted by BioCentury Inc. and BayHelix. Five years ago, the first China Healthcare Summit asked how the nation would build the "Bridg...

Innovent Receives an Approval from the US FDA to Initiate Clinical Trials for its Anti-OX40 Monoclonal Antibody IBI101

SUZHOU, China, Dec. 5, 2018 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, announced today that its IND application for IBI101, a recombinant fully human anti-OX40 monoclonal antibody (mAb) drug candidate, has been approved by the US Food & Drug Administration (FDA), and...

Tuesday 4th December 2018

CARsgen Presents Preliminary Results of CAR-BCMA T Cell Therapy at ASH 2018

SHANGHAI, Dec. 4, 2018 /PRNewswire/ -- CARsgen Therapeutics, a clinical-stage company committed to developing Chimeric Antigen Receptor T cell therapies for cancer, presented initial safety and efficacy results from its ongoing investigational study of CT053 for patients with relapsed/refractory multiple myeloma (R/R MM) at the 60th American Society of Hematology (ASH) Annual Meeting in San Diego....

Ping An Good Doctor Showcases Cutting-edge AI Medical Technology Achievements at 80th Pharm China

GUANGZHOU, China, Dec. 4, 2018 /PRNewswire/ -- China's leading one-stop healthcare ecosystem platform, Ping An Health Medical Technology Company Limited ("Ping An Good Doctor") (stock code: 01833.HK) attended the 80th Session of the National Pharmaceuticals Trade Fair ("Pharm China"), where the Company showcased a number of its cutting-edge artificial intelligence (AI) medical ...

EP & Clean Tech China 2019 to Gather Clean Pharmaceutical Technical Equipment and Assist with Green Production of Clean Plants

SHANGHAI, Dec. 4, 2018 /PRNewswire/ -- Regulation and standards for "clean plants" have been increasing in recent years as China's pharmaceutical R&D and production industry develops rapidly. EP & Clean Tech China 2019, hosted by CCCMHPI, UBM EMEA and UBM Sinoexpo, is an annual event of the pharma clean industry, that will blow a strong, new pharma clean wind in Hall N4 of S...

AGC Enters Agreement to Acquire Synthetic Pharmaceutical Active Ingredient-manufacturing Plant in Spain

- Acquisition Will Give AGC Foothold in Europe and Broaden Its Pharma CDMO Business - TOKYO, Dec. 4, 2018 /PRNewswire/ -- AGC Inc., a world-leading manufacturer of glass, chemicals and high-tech materials, has announced that it has entered into an agreement with Boehringer Ingelheim to acquire Malgrat Pharma Chemicals S.L.U. ("MPC"). MPC is a subsidiary of Boehringer Ingelheim that man...

Hankuk Bowon Bio Co.,Ltd (HBBIO), Precious Serpentine necklace set 'HABIBI' released in Indonesia, encourages healthy immune systems

HABIBI, a natural rare earth element necklace and bracelet collection to be released in December. SEOUL, South Korea, Dec. 4, 2018 /PRNewswire/ -- Hankuk Bowon Bio Co.,Ltd (HBBIO) announced that they will be releasing their premium Precious Serpentine necklace set, HABIBI, on the Indonesian market in December, 2018. HABIBI necklace The HABIBI precious serpentine Necklace and Bracelet...

Herbalife Nutrition Scientist Dr. Zhengfei Lu to Present Illustration of Industry-Leading DNA Technologies for Quality Control of Botanicals

HONG KONG, Dec. 4, 2018 /PRNewswire/ -- Herbalife Nutrition (NYSE:HLF), a premier global nutrition company whose purpose is to make the world healthier and happier, has been confirmed as a mainstage presenter for "The 2nd International Conference on DNA Technology for Authentication, Quality Control and Conservation of Herbal Material", held from December 2 to 5 by the Chinese Univer...

Monday 3rd December 2018

World Institute of Kimchi: Kimchi is effective in treating Alzheimer's disease

- Learning and memory functions were maintained in Alzheimer's disease-induced mice after kimchi diet - Results of providing five antioxidant-rich ingredients in kimchi to mice by Professor Yeong Ok Song's team at Pusan National University are presented - These results were published in a recent issue of Nutrients ...

Data Presented at 2nd Healthy Lung Summit 2018 to Demonstrate Impact of AstraZeneca's Healthy Lung Partnership Programme

Deepening commitment to drive improvements for patients with respiratory disease across Asia, AstraZeneca with Business Sweden, The Swedish Trade & Invest Council in Taiwan, hosts the second Healthy Lung Summit, ahead of the 2018 Asia Pacific Society of Respirology Meeting

LABWorld China 2019 to Gather Pharmaceutical Biochemical and Analytical Instruments and Focus on Cutting-edge Laboratory Technology

SHANGHAI, Dec. 3, 2018 /PRNewswire/ -- LABWorld China 2019, hosted by CCCMHPI, UBM EMEA and UBM Sinoexpo, will be held at Shanghai New International Expo Centre (SNIEC) on June 18-20, 2019. As an industry weather vane, LABWorld China 2019 will focus on R&D, inspection and analysis in the pharmaceutical chemical and biotechnology fields, and set up a bridge of communication between th...

2018 FIDO Taipei Seminar: Latest global trends in authentication and identification technologies

FIDO and Egis Technology co-organized the event TAIPEI, Taiwan, Dec. 3, 2018 /PRNewswire/ -- 2018 FIDO Taipei Seminar, jointly organized by the FIDO (Fast Identity Online) Alliance and Egis Technology Inc., was held in Taipei on Nov. 30. Themed "No More Passwords", the event brought together professionals from around the world to discuss updates and future trends ...

Gilead Sciences Announces Recipients of Asia Rainbow Grants Program

-- Grants Program Supports Projects that Engage Young Adults and Communities Affected by HIV/AIDS --  -- Recipients Include Non-profit Organizations From Across 10 Asian Markets -- HONG KONG, Dec. 3, 2018 /PRNewswire/ -- Gilead Sciences, Inc. today announced the recipients of the Gilead Asia Rainbow Grants program. Launched in September of this year, ...

Friday 30th November 2018

Mundipharma CEO Raman Singh Wins Global Executive of the Year -- For Private Pharma Companies at Industry-Leading Scrip Awards

The Scrip Awards are the leading global awards for the pharmaceutical sector and recognize excellence and responsibility. Mr. Singh's win further enhances Mundipharma's status as a global healthcare leader SINGAPORE, Nov. 30, 2018 /PRNewswire/ -- Mundipharma CEO, Raman Singh, has won Executive of the Year -- For Small Cap & Private Pharma Companies at th...

Innovent Announces Global Collaboration with Hutchison MediPharma to Evaluate Combination of Sintilimab and Fruquintinib in Solid Tumors

- Global collaboration will initially evaluate Innovent's anti-PD-1 monoclonal antibody sintilimab in combination with Hutchison MediPharma's VEGFR inhibitor fruquintinib for solid tumors - SUZHOU, China, Nov. 30, 2018 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 1801),  a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks